otosclerosis
TRANSCRIPT
OTOSCLEROSIS Moderator-Dr.Mohan Presenter-Dr.Razal
2
Definition
A primary disease of the bony otic capsule characterized by abnormal removal of mature bone by osteoclasts and replacement with woven bone of greater thickness, cellularity and vascularity.
Clinical Otosclerosis refers to a lesion that involves the stapes bone or stapidovestibular joint.
Most common site is fissula ante fenestram
(anterior to the stapes foot plate) and also seen in the fossula post fenestram (area in front and behind oval window)
The bone of otic capsule is unique that it exhibits very low remodeling and contains small regions of immature cartilaginous tissue called GLOBULI INTEROSSEI.
Blue Mantles, an earliest histological alterations of otic capsule that stain more basophilic.
4
Epidemiology
Race % incidence ofCaucasian 10%Asian 5%African American 1%Native American 0%
Epidemiology
Gender Histologic otosclerosis – 1:1 ratio Clinical otosclerosis – 2:1 (W:M)• Increase progression during pregnancy (10%-17%)• Bilaterality more common (89% vs. 65%)
Epidemiology
Age• 15-45 most common age range of presentation• Youngest presentation7 years • Oldest presentation 50s• 0.6% of individuals <5 years old have foci of
otosclerosis
8
Etiology
The exact cause is unknown but many factors have been proposed such as:
• Genetic• Autoimmune• Infections• Endocrine (pregnancy)• Trauma• Vascular
• Hereditary(Autosomal Dominant)• More common in whites than blacks• Uncommon in Asian • Sporadic cases were reported.• Defects in COL1A1 Gene• defects in expression of the COLlAl gene has
revealed a significant association between both familial and sporadic cases
Genetic
Type 1 osteogenesis imperfecta shares both
clinical and histologic similarities with otosclerosis.
Half of all patients with type 1 osteogenesis imperfecta develop hearing loss that is clinically indistinguishable from clinical otosclerosis.
Patients with clinical otosclerosis have blue sclera, a feature that is found in all patients with type 1 osteogenesis imperfecta.
Osteogenesis Imperfecta
11
Infectious (Measles)
Measles RNA was found in footplate specimens
Elevated levels of anti measles antibody found in perilymph from patent undergoing stapedectomy.
12
a form of autoimmune disease with humoral
autoimmunity to Type II collagen.
Elevated circulating antibodies to type II collagen are found in patients of otosclerosis
Autoimmune
13
Pathogenesis
Affects the Otic and labyrinth Capsule
Enlargement of the Perivascular SpaceBone Absorption by osteoclast activityNew Bone deposition by osteocytes Containing vascular space in center Lamellar Bone
With time mucoperiostium of middle ear increases in thickness and becomes vascularReddish Hue through the TM and disease advances
Involvement of Bony labyrinth
Involvement of foot plate.
Cochlear Otosclerosis
Stapedial Otosclerosis
Histologically
Lesion can be divided into Active-Spongy structure immature osseous
tissue with numerous dilated vascular channels with osteoclastic giant cells
Inactive/Mature• End stage of bone transformation ,characterized
by solid compact lamellar tissue. Siebenmann – first to describe the microscopic appearance
16
The foci demonstrates two phases: Early spongiotic phase (otospongiosis)
Osteocytes, histiocytes, osteoclasts Active reabsorption of bone Stains blue (blue mantles) on using H&E stain Dilated vessels (Schwartze’s sign)
Late or Sclerotic phase Formation of new bone in resorption areas New bone is dense and sclerotic Stains red on using H&E stain Starts in endochondral bone then involves endosteal
& periosteal layers and membranous labyrinth as disease progress
17
Anterior Focus
Most common, at fissula ante fenestram Posterior Focus
Lesion spreading from posterior oval window to annular ligament
Circumferential Lesion flows across the ligament totally obliterating
the annular ligament Biscuit type
Lesion replacing entire footplate, but no involvement of annular ligament leading to a solid footplate
Types of Stapedial fixation
18
Obliterative
Completely obliterates the oval window Other areas are:
Round window, the apex of the cochlea, the cochlear aqueduct, the semicircular canals, and the stapes footplate itself
Types of Stapedial fixation
19
Diagnosis
20
Gradual onset of hearing loss progressing
slowly In 70% cases hearing loss is bilateral Usually becomes apparent around the age of
30 Loss noticeable when it reaches 25 to 30 dB Unilateral loss noticed even later, problem
with localization of sound Positive family history
History
SYMPTOMS
Low modulated voice (BC is more ,patients hears their own voice.
Deafness-Mainly Conductive hearing loss, Paracussis Willisi-Patient will hear better in
noisy surroundings. Tinnitus Vertigo
Clinical Features
22
Hearing Loss
Conducting Hearing Loss (CHL)• Stapedial fixation• Hearing impairment ranging from 5dB to 60dB.• Caused primarily by narrowing and impairment of the
annular ligament, at the posterior stapediovestibular joint space.
Sensorineural Hearing Loss (SNHL)• Cochlear otosclerosis • the sensory and neural elements of the cochlea, such
as hair cells, spiral ganglion cells and stria vascularis, are intact or their impairment is insufficient to account for the observed sensorineural hearing impairment.
23
OTOSCOPY• SCHWARTZE SIGN:- red blush color occasionally
seen over promontory or anterior to oval window• Pneumo-otoscopy used to rule out other causes of
CHL such as middle ear serous fluid or small perforation
TUNING FORK TEST• Hearing loss progresses form low frequencies to high frequencies• Rinne Test-Negative• Weber Test-Laterlized to worst ear.• ABC-Normal
Physical Examination
Pure Tone Audiometry
CARHART’S NOTCH Proposed theory
Stapes fixation disrupts the normal ossicular resonance (2000 Hz)
Normal compressional mode of bone conduction is disturbed because of relative perilymph immobility
Mechanical artifact Reverses with stapes mobilization
Speech Audiometry Normal except in those with cochlear
involvement.
26
Tympanometry : As type curve
Impedance
27
High resolution CT scan
Shows subtle areas of demineralization In case of cochlear involvement it shows
“double ring sign” MRI
Done for patients with unusual presentation Detects congenital anomalies of cochlea Excludes retrocochlear pathology eg. Acoustic
neuroma
Radiological Investigations
Differential Diagnosis
Ossicular discontinuity Congenital stapes fixation Malleus head fixation Paget’s disease Osteogenesis imperfecta
29
TREATMENT
30
Treatment Options
Hearing aid
Medical management
Surgical management-The ‘Gold’ reference standard of Diagnosis is Surgery
31
Hearing Aid
Very effective in early stage of disease But can be used in advance stage, if:
Surgery is contraindicated Patient refuses the surgery In far-advance cases it is required, even
after stapedotomy
32
Medical Management Aim is to Stabilize the disease by
reduction of the osteoclastic bone resorption increase osteoblastic bone formation
Inhibits proteolytic enzymes that are cytotoxic to cochlea.
Slows the progression of sensorineural hearing loss
Not commonly used
33
Tab. Sodium fluoride
Dose : 50 – 75 mg/day ODDuration : 3 months – 2 years
Function helps to hasten the maturity of active focus and arrest further progression of cochlear loss
It has antienzymatic action on proteolytic enzymes which are cytotoxic to cochlea.
Indications: Cochlear otosclerosis Active stapedial otosclerosis
Sodium Fluoride Therapy
Side effects : Fracture of long bones and spine due to fluorosis. Nephritis. Gastritis
Contraindications: Pregnancy & lactation Patient with kidney stones / nephritis Patient with RA
Sodium Fluoride Therapy
35
Surgical Management Poorer ear always chosen for surgery Done preferably under local anesthesia so patient
can notify surgeon if vertigo occurs during procedure
Options are: Stapedotomy Stapedectomy
Lasers -Lesser complications
THANK YOU